单视角数字乳腺断层合成与双视角乳腺X线摄影在马尔默筛查试验中的诊断准确性比较
马尔默乳腺断层合成筛查试验(MBTST)是一项前瞻性人群筛查研究,纳入14 848名40-74岁女性,比较单视角数字乳腺断层合成(DBT)与标准双视角数字乳腺X线摄影(DM)的筛查准确性。
核心结论
- 单视角DBT联合降低压迫力筛查较双视角DM敏感度更高、特异度略低,且可能减少辐射剂量和阅片负担。
研究设计与样本
- 前瞻性、人群为基础的诊断准确性研究,纳入14 848名40-74岁受邀参加瑞典马尔默乳腺癌筛查的女性。
- 所有参与者同一次筛查中先后接受双视角DM和单视角DBT(降低压迫力,宽角度50°),采用掩蔽双读法由两组各7名放射科医生独立评分。
- 主要结局为乳腺癌检测的敏感度和特异度,随访至少2年以识别间期癌。
临床怎么用
- 单视角DBT可提高乳腺癌筛查敏感度和癌症检出率,但需注意召回率略增。
- 该技术可能降低辐射剂量和阅片负担,但特异度略低于双视角DM。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Digital breast tomosynthesis is an advancement of the mammographic technique, with the potential to increase detection of lesions during breast cancer screening. The main aim of the Malmö Breast Tomosynthesis Screening Trial (MBTST) was to investigate the accuracy of one-view digital breast tomosynthesis in population screening compared with standard two-view digital mammography. METHODS: In this prospective, population-based screening study, of women aged 40-74 years invited to attend national breast cancer screening at Skåne University Hospital, Malmö, Sweden, a random sample was asked to participate in the trial (every third woman who was invited to attend regular screening was invited to participate). Participants had to be able to speak English or Swedish and were excluded from the study if they were pregnant. Participants underwent screening with two-view digital mammography (ie, craniocaudal and mediolateral oblique views) followed by one-view digital breast tomosynthesis with reduced compression in the mediolateral oblique view (with a wide tomosynthesis angle of 50°) at one screening visit. Images were read with masked double reading and scoring by two separate reading groups, one for each method, made up of seven radiologists. Any cancer detected with a malignancy probability score of three or higher by any reader in either group was discussed in a consensus meeting of at least two readers, from which the decision of whether or not to recall the woman for further investigation was made. The primary outcome measures were sensitivity and specificity of breast cancer detection. Secondary outcome measures were screening performance measures of cancer detection, recall, and interval cancers (cancers clinically detected between screenings), and positive predictive value for screen recalls and negative predictive value of each method. Outcomes were analysed in the per-protocol population. Follow-up of the participants for at least 2 years allowed for identification of interval cancers. This trial is registered with ClinicalTrials.gov, number NCT01091545. FINDINGS: Between Jan 27, 2010, and Feb 13, 2015, of 21 691 women invited, 14 851 (68%) agreed to participate. Three women withdrew consent during follow-up and were excluded from the analyses. 139 breast cancers were detected in 137 (<1%) of 14 848 women. Sensitivity was higher for digital breast tomosynthesis than for digital mammography (81·1%, 95% CI 74·2-86·9, vs 60·4%, 52·3-68·0) and specificity was slightly lower for digital breast tomosynthesis than was for digital mammography (97·2%, 95% CI 97·0-97·5, vs 98·1%, 97·9-98·3). The proportion of cancers detected was significantly higher with digital breast tomosynthesis than with digital mammography (8·7 cancers per 1000 women screened, 95% CI 7·3-10·3 vs 6·5 cancers per 1000 screened, 5·2-7·9; p<0·0001). The proportion of women recalled after discussion was higher among cancers detected by digital breast tomosynthesis than for those detected by digital mammography after consensus (3·6%, 95% CI 3·3-3·9 vs 2·5%, 2·2-2·8; p<0·0001). The positive predictive value for screen recalls was 24·1% (95% CI 20·5-28·0) for digital breast tomosynthesis and 25·9% (21·6-30·7) for digital mammography, and the negative predictive value was 99·8% (99·7-99·9) and 99·6% (99·4-99·7), respectively. The proportion of women who developed interval cancers after trial screening was 1·48 cancers per 1000 women screened (95% CI 0·93-2·24). INTERPRETATION: Breast cancer screening by use of one-view digital breast tomosynthesis with a reduced compression force has higher sensitivity at a slightly lower specificity for breast cancer detection compared with two-view digital mammography and has the potential to reduce the radiation dose and screen-reading burden required by two-view digital breast tomosynthesis with two-view digital mammography. FUNDING: The Swedish Cancer Society, The Swedish Research Council, The Breast Cancer Foundation, The Swedish Medical Society, The Crafoord Foundation, The Gunnar Nilsson Cancer Foundation, The Skåne University Hospital Foundation, Governmental funding for clinical research, The South Swedish Health Care Region, The Malmö Hospital Cancer Foundation and The Cancer Foundation at the Department of Oncology, Skåne University Hospital.
引用
- Zackrisson S, Lång K, Rosso A, et al. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study. Lancet Oncol. 2018. PMID: 30322817. doi:10.1016/S1470-2045(18)30521-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。